| Name | Title | Contact Details |
|---|---|---|
Kelly Brown |
Interim Associate Dean and Chief Information Officer | Profile |
Uduak Ndoh |
Chief Information Officer and Associate Dean for Information Technology | Profile |
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Institute for Work and Health is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1947, Hill Top Research is one of the world's leading clinical research services companies with research centers throughout North America. Hill Top Research provides services including clinical research, microbiology, and CRO services for the
Your partner in Care is a Wakefield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hematech, Inc was founded in 1998, with corporate headquarters in Sioux Falls, SD. Hematech is a subsidiary of Kyowa Hakko Kirin Company, Ltd. In 2002, Hematech and Kirin consolidated their transgenic bovine research programs in facilities in Sioux